Show simple item record

Altered properties of human t-lymphoblast soluble low Km 5'-nucleotidase: Comparison with B-lymphoblast enzyme

dc.contributor.authorMadrid-Marina, Vicenteen_US
dc.contributor.authorLestan, Borisen_US
dc.contributor.authorNowak, Paul J.en_US
dc.contributor.authorFox, Irving H.en_US
dc.contributor.authorSpychala, Jozefen_US
dc.date.accessioned2006-04-10T15:52:08Z
dc.date.available2006-04-10T15:52:08Z
dc.date.issued1993-03en_US
dc.identifier.citationMadrid-Marina, Vicente, Lestan, Boris, Nowak, Paul J., Fox, Irving H., Spychala, Jozef (1993/03)."Altered properties of human t-lymphoblast soluble low Km 5'-nucleotidase: Comparison with B-lymphoblast enzyme." Leukemia Research 17(3): 231-240. <http://hdl.handle.net/2027.42/30943>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6T98-4BP9V2P-2T/2/4d6945d18a6cc0a04b56a6fd4dbf2ddeen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/30943
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8450671&dopt=citationen_US
dc.description.abstractSoluble low Km 5'-nucleotidases have been purified from human cultured T- and B-lymphoblasts to compare their properties and to examine the mechanism of different rates of nucleotide dephosphorylation. The enzyme from B-lymphoblasts (MGL-8) was 4385-fold purified with a specific activity of 114 [mu]mol/min/mg, while the enzyme from T-lymphoblasts (CEM, MOLT-4) was 4355-fold purified with a specific activity of 35 [mu]mol/min/mg. The activity of both enzymes have an absolute requirement for Mg++. The B-cell enzyme has maximum activity with Mg2+ &gt; Mn2+ &gt; Co2+, while the T-cell enzyme had maximum activity with Co2+ &gt; Mn2+ &gt; Mg2+. The optimum activity was at pH 7.4-9.0 for the B-cell enzyme and pH 9.0 for the T-cell enzyme. Substrate specificity was the same for both enzymes with the following relative Vmax values: CMP &gt; UMP &gt; dUMP &gt; dCMP &gt; dAMP &gt; IMP &gt; GMP &gt; dIMP &gt; dGMP. The Km values for AMP and IMP were 12 and 25 [mu]M for the B-cell enzyme, and 7.0 and 12 [mu]M for the T-cell enzyme. ATP and ADP are competitive inhibitors of these enzymes with apparent Ki values of 100 and 20 [mu]M for the B-cell enzyme, and 44 [mu]M and 8 [mu]M for the T-cell enzyme, respectively. The apparent molecular mass by gel filtration column chromatography is 145 kD for the B-cell enzyme and 72 kDa for the T-cell enzyme. The subunit molecular masses by Western blots are 69.2 kD for both enzymes.These properties suggest that the B-lymphoblast enzyme is identical or similar to the enzyme from human placenta. However, the T-cell enzyme has some different properties. We conclude that these differences plus a lower content of low Km 5'-nucleotidase in T-cells may account for the decreased ability of T-lymphoblasts to dephosphorylate nucleotides and may contribute to the selective cytotoxicity of deoxyribonucleosides for T-lymphoblasts as compared to B-lymphoblasts.en_US
dc.format.extent972756 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleAltered properties of human t-lymphoblast soluble low Km 5'-nucleotidase: Comparison with B-lymphoblast enzymeen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumThe University of Michigan, Department of Internal Medicine, Division of Rheumatology, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationumThe University of Michigan, Department of Internal Medicine, Division of Rheumatology, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationumThe University of Michigan, Department of Internal Medicine, Division of Rheumatology, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationumThe University of Michigan, Department of Internal Medicine, Division of Rheumatology, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationumThe University of North Carolina, Department of Pharmacology, Chapel Hill, NC 27599, U.S.A.; University of Michigan, Department of Internal Medicine, Division of Rheumatology, Ann Arbor, MI 48109, U.S.A.en_US
dc.identifier.pmid8450671en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/30943/1/0000614.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0145-2126(93)90006-7en_US
dc.identifier.sourceLeukemia Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.